Article info
Syndicated article
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
- Correspondence to: Dr B Ryan, Department of Gastroenterology, University Hospital Maastricht, PO Box 5800, 6202AZ, Maastricht, the Netherlands; bbryan{at}planet.nl
Citation
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Publication history
- Accepted April 30, 2002
- First published June 1, 2003.
Online issue publication
June 01, 2003
. Reprinted with Permission from Gut
Reprinted with Permission from Gut
Files in this Data Supplement:
- Reprinted with Permission from Gut - Reprinted with Permission from Gut
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 Journal of Clinical Pathology